Back to search
FDAFDA · Food and drugs·Recall number Z-0592-2024

Catalog No. 800 TRACHEOSTOMY CARE TRAY - STERILE -LATEX FREE

Published January 10, 2024 · Recall initiated: November 30, 2023

Summary

FDA records medical device Class I recall Z-0592-2024, published January 10, 2024 and initiated November 30, 2023. Recalling firm: Busse Hospital Disposables, Inc.; Status: Ongoing; Reported quantity: 705; Lot: UDI-DI 00849233010000 Lots 2210099 2210135 2210337 2210377 2310181 2310233 2310291. Class I means a reasonable probability of serious adverse health consequences or death.

Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Firm is recalling all kits containing recalled lots of Nurse Assist Sterile 0.9% Normal Saline. Nurse Assist identified product in distribution for which the required sterility assurance level (SAL) of 10^-6 cannot be guaranteed. Risks to patients if product is used include blood stream infections, urinary tract infections, or respiratory infections; in the worst-case scenario, there is risk of sepsis or death.

What to do

Voluntary: Firm initiated · Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Busse Hospital Disposables, Inc.
Distributor
US Nationwide distribution.
Lot
UDI-DI 00849233010000 Lots 2210099 2210135 2210337 2210377 2310181 2310233 2310291
Risk classification
Class I
Area (FDA)
device
Country
United States

Related recalls

Questions about this recall

Was Catalog No. 800 TRACHEOSTOMY CARE TRAY - STERILE -LATEX FREE recalled?

Yes. FDA published recall Z-0592-2024 on January 10, 2024. Reported hazard: Firm is recalling all kits containing recalled lots of Nurse Assist Sterile 0.9% Normal Saline. Nurse Assist identified product in distribution for which the required sterility assurance level (SAL) of 10^-6 cannot be guaranteed. Risks to patients if product is used include blood stream infections, urinary tract infections, or respiratory infections; in the worst-case scenario, there is risk of sepsis or death.

What should I do if I have this product?

Voluntary: Firm initiated · Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit